glp 1 agonist natural alternative GLP-1 and GIP Supplements: Evidence and Safety – Bolt Pharmacy Research shows GLP-1 drugs are

The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019

Retatrutide is still in clinical trials and not yet available

May have higher risk of GI or metabolic side effects

& Singh, P

This meta-analysis indicates that GLP-1 receptor agonists are safe and effective in modestly reducing weight, BMI, glycated hemoglobin A1c, and systolic blood pressure in children and adolescents with obesity in a clinical setting, albeit with increased rates of nausea [17]

However, if Eli Lilly's follow-up products help it maintain its edge, the market will continue to consider it one of the top GLP-1 stocks, enabling it to sustain a premium valuation